Germany · Biotechnology startup
Germany · SuppreMol
SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders.
Funding reportedLast round: Series D
What company datasets say SuppreMol raised
Funding, as reported
Reported in all71Min the source's currency
Rounds5
Last roundSeries D
Last round dateMay 2013
Investors listed8
How it ended, so far
Exit
ExitBuyerPriceWhen
AcquiredBaxter InternationalundisclosedMar 2015
Biotechnology in Germany
Startups like it
Is this your company?
Add your raise, your deck and your story, and put SuppreMol in front of investors. Or tell us what we have wrong.